Journals / Erciyes Tıp Dergisi / 2013 / Cilt: 35 - Sayı: 3

Karotis arter stentlemesi sonrası 48 saat içinde koroner arter baypas greft operasyonu güvenli mi?

Pages
148–152
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: CABG-O in 48 hours following CAS is safe and not related to increasing the rate of AMI, stroke and death at 19 months of follow up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study was to assess the safety and effectiveness of the outcome of coronary artery bypass graft operation (CABG-O) in 48 hours following carotid artery stenting (CAS).
📊
Key Findings & Data:The mean time from CAS to CABG-O was 15.7±7 hours (range 8-48 hours).
💡
Conclusion & Impact:Conclusion: CABG-O in 48 hours following CAS is safe and not related to increasing the rate of AMI, stroke and death at 19 months of follow up.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study was to assess the safety and effectiveness of the outcome of coronary artery bypass graft operation (CABG-O) in 48 hours following carotid artery stenting (CAS). Materials and Methods: We report the results of a retrospective, single-center study designed to evaluate the feasibility and safety of CAS before cardiac surgery in neurologically symptomatic or asymptomatic patients. Twenty-three patients to whom CAS was applied because of symptomatic or asymptomatic carotid vascular stenosis were included in the study. CAS was accomplished in all patients without any complication. The mean time from CAS to CABG-O was 15.7±7 hours (range 8-48 hours). All patients were followed up for 19 months (range, 9-47 months) for any adverse events such as stroke, acute myocardial infarction (AMI), stent restenosis and death. Results: Most patients with carotid artery lesion were asymptomatic (82.6%). Stroke and AMI did not occur in any CAS patients during the procedure and the time interval between CAS and CABG-O. Major stroke was observed in one patient at the arm of CAS, on the first day postoperatively. Conclusion: CABG-O in 48 hours following CAS is safe and not related to increasing the rate of AMI, stroke and death at 19 months of follow up.

🔖

Cite This Article

BOZOĞLAN, O., ÖZDEMİR, L., MERCAN, H., KIRMAN, M., ERDEM, K., DÖNMEZ, H. (2022). Karotis arter stentlemesi sonrası 48 saat içinde koroner arter baypas greft operasyonu güvenli mi?. Erciyes Tıp Dergisi, Cilt: 35 - Sayı: 3, 148–152. https://ajindex.com/articles/502387

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Abbott AL, Chambers BR, Stork JL, Levi CR, Bladin CF Donnan GA. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke. 2005; 36(6): 1128-33
  2. Borger MA, Fremes SE, Weisel RD, Cohen G, Rao V Lindsay TF et al. Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A meta analysis. Ann Thorac Surg 1999; 68(1): 14-20
  3. Babatasi G, Massetti M, Theron J. Coexistent coronary and cerebrovascular disease: a place for carotid stenting. Ann Thorac Surg 1999; 68(1): 297
  4. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005; 19(4): CD001923
  5. ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the AmericanCollege ofCardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/ SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). Journal of the American College of Cardiology. 2007; 49(1): 126-70
  6. Naylor AR, Cuffe RL, Rothwell PM, Bell PR. A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass. Eur J Vasc Endovasc Surg 2003; 25(5): 380-9
  7. Das SK, Brow TD, Pepper J. Continuing controversy in the management of concomitant coronary and carotid disease: an overview. Int J Cardiol 2000; 74(1): 47-65
  8. U.S. Food and Drug Administration. ACCULINKTM and RX ACCU- LINKTM Carotid Stent System - P040012. [Accessed September 26, 2008]. Available at
  9. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998; 279(16): 1278-81
  10. Gray WA, Chaturvedi S, Verta P Thirty-day outcomes for carotid artery stenting in 6320 patients from 2 prospective, multicenter, highsurgi- cal- risk registries. Circulation Cardiovascular Interventions 2009; 2(3): 159-66
  11. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/ AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 1999; 10